Scilex Approves 10.7M Semnur Share Dividend with June 1 Record Date
Scilex Holding Company’s Board approved a dividend of Semnur Pharmaceuticals common stock to Scilex common stockholders and eligible equityholders, with a June 1, 2026 record date. Scilex will distribute approximately 10.7 million shares from its 186 million-share Semnur position, with payment set within 60 days of the record date.
1. Dividend Approval and Terms
On May 22, Scilex’s Board of Directors approved a one-for-one dividend of Semnur Pharmaceuticals common stock, entitling each Scilex common share and certain eligible equity securities to one Semnur share. Based on Scilex’s current holding of approximately 186 million Semnur shares, the company plans to distribute about 10.7 million shares to participating holders.
2. Record Date and Payment Conditions
The record date for determining participating holders is set for June 1, 2026; however, the Board retains the right to change this date or revoke the dividend before payment. The actual payment date will be determined by subsequent Board resolutions and will occur within 60 days of the record date, provided no material changes affect the company’s solvency analysis.
3. Scilex’s Semnur Shareholding
Prior to the dividend, Scilex holds roughly 186 million shares of Semnur Pharmaceuticals, a clinical late-stage specialty pharmaceutical company focused on non-opioid pain therapies. This distribution reduces Scilex’s share count in Semnur while returning value directly to Scilex equityholders without impacting cash reserves.